ZSCAN1 and neoplasm: Finally, we analyzed the anti-ZSCAN1 autoantibody positivity in a cohort of 14 patients with ROHHAD syndrome not associated with a tumor, 15 normal subjects, and 5 subjects with autoimmune disorders (Table 3).